With our decades of experience in infection and airway research, drug development, biomedical engineering, and in the field of chemical risk assessment, we are meanwhile involved in numerous projects to fight the COVID-19 pandemic.
more info© Fraunhofer
Get some insights into our clinical airway research in our video series #WeKnowClinicalResearch.
more infoProf. Dr. Dr. Thomas Thum has joined Fraunhofer ITEM as institute director. He will henceforth manage the institute together with Prof. Dr. Norbert Krug.
more infoOur Regensburg-based Division of Personalized Tumor Therapy is searching for approaches for novel diagnostics and personalized treatments in the fight against cancer.
more info© Fraunhofer ITEM, P. Reinig
New fast-track method cuts many months off the time required for process development.
more info© Fraunhofer ITEM, Ralf Mohr
Development of an open-innovation test bed to support small and medium-sized manufacturers of medical devices in the conformity assessment of their products.
more info© © Shutterstock, Yurchanka Siarhei
Processing large quantities of data is a major challenge of our era, in the life sciences in particular. The Project Group for Bioinformatics has been set up as an “Attract Group” at Fraunhofer ITEM.
more info© Vasily Smirnov, stock.adobe.com
Fraunhofer scientists have joined forces with partners in the Phage4Cure project to explore alternatives to antibiotics.
more info© peterschreiber.media - stock.adobe.com
The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of 75 institutes and research institutions of the Fraunhofer-Gesellschaft, the world’s leading applied research organization. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on airway research, our R&D portfolio includes three thematic areas: drug development, chemical safety, and translational biomedical engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.
With a staff of 394 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.
More information about Fraunhofer ITEM
Fraunhofer Institute for Toxicology and Experimental Medicine